![](https://www.ucl.ac.uk/psychopharmacology/sites/psychopharmacology/files/styles/medium_image/public/grouppic.jpg?itok=OVd5kKFd)
![](https://www.ucl.ac.uk/psychopharmacology/sites/psychopharmacology/files/styles/medium_image/public/CPUpicTomChandniWill.jpg?itok=maoO6YYV)
![](https://www.ucl.ac.uk/psychopharmacology/sites/psychopharmacology/files/styles/medium_image/public/festival-demo.jpg?itok=UE7I0cr_)
![](https://www.ucl.ac.uk/psychopharmacology/sites/psychopharmacology/files/styles/medium_image/public/image7.jpg?itok=75akaLl3)
![](https://www.ucl.ac.uk/psychopharmacology/sites/psychopharmacology/files/styles/medium_image/public/cannteenteam.jpg?itok=sxKSXD8s)
The researchers in the Clinical Psychopharmacology Unit (CPU) aim to understand the intersection between drugs and the brain and mind, in order to develop the next-generation of treatments to improve mental health.
We are a multidisciplinary lab, incorporating psychologists, neuroscientists and clinicians and our research spans basic psychological science to world-first clinical trials.